Cellular Biomedicine Group Inc (CBMG:NASDAQ) Investor Relations Material

Overview

Cellular Biomedicine Group Inc. is a biomedicine company that operates in Greater China and specializes in the treatment of cancerous and degenerative diseases. The company primarily focuses on developing and marketing cell-based therapies that target chronic and degenerative diseases, including cancer, osteoarthritis, various inflammatory diseases, and metabolic diseases. With a commitment to improving patient outcomes and enhancing the quality of life for those suffering from serious illnesses, Cellular Biomedicine Group Inc. is poised to make a significant impact on the healthcare industry in Greater China and beyond.

Frequently Asked Questions

What is Cellular Biomedicine Group Inc's ticker?

Cellular Biomedicine Group Inc's ticker is CBMG

What exchange is Cellular Biomedicine Group Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Cellular Biomedicine Group Inc's headquarters?

They are based in Cupertino, California

How many employees does Cellular Biomedicine Group Inc have?

There are 1-10 employees working at Cellular Biomedicine Group Inc

What is Cellular Biomedicine Group Inc's website?

It is http://www.cellbiomedgroup.com/

What type of sector is Cellular Biomedicine Group Inc?

Cellular Biomedicine Group Inc is in the Healthcare sector

What type of industry is Cellular Biomedicine Group Inc?

Cellular Biomedicine Group Inc is in the Biotechnology industry

Who are Cellular Biomedicine Group Inc's peers and competitors?

The following five companies are Cellular Biomedicine Group Inc's industry peers:

- Baudax Bio, Inc.

- IVERIC bio

- Emergent BioSolutions

- CASI Pharmaceuticals Inc

- Aimmune Therapeutics, Inc.